Sanofi (SNYN) — Capital Reinvestment Ratio
Latest as of December 2025:
0.33x
Sanofi (SNYN) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow (MX$10.75 Billion) in capital expenditures (MX$3.54 Billion). See SNYN equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.33x
Capex / Operating Cash Flow
Operating Cash Flow
MX$10.75 Billion
MXN
Capital Expenditures
MX$3.54 Billion
MXN
Data as of
Dec 2025
Most recent filing
Sanofi Capital Reinvestment Ratio (2013–2025)
This chart tracks Sanofi's Capital Reinvestment Ratio across 13 annual periods. Check SNYN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sanofi (2013–2025)
Year-by-year Capital Reinvestment Ratio for Sanofi from 2013 to 2025. For live market cap and broader valuation context, see SNYN market cap overview.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | MX$10.75 Billion | MX$3.54 Billion | ▼ -6.5% |
| 2024 | 0.35x | MX$9.08 Billion | MX$3.19 Billion | ▲ +19.3% |
| 2023 | 0.29x | MX$10.26 Billion | MX$3.02 Billion | ▲ +93.2% |
| 2022 | 0.15x | MX$10.53 Billion | MX$1.61 Billion | ▲ +8.5% |
| 2021 | 0.14x | MX$10.52 Billion | MX$1.48 Billion | ▼ -16.9% |
| 2020 | 0.17x | MX$7.42 Billion | MX$1.25 Billion | ▼ -1.4% |
| 2019 | 0.17x | MX$7.71 Billion | MX$1.32 Billion | ▼ -32.8% |
| 2018 | 0.26x | MX$5.55 Billion | MX$1.42 Billion | ▲ +35.6% |
| 2017 | 0.19x | MX$7.38 Billion | MX$1.39 Billion | ▼ -29.2% |
| 2016 | 0.27x | MX$7.84 Billion | MX$2.08 Billion | ▲ +97.1% |
| 2015 | 0.13x | MX$8.92 Billion | MX$1.20 Billion | ▼ -28.6% |
| 2014 | 0.19x | MX$7.69 Billion | MX$1.45 Billion | ▲ +0.6% |
| 2013 | 0.19x | MX$6.95 Billion | MX$1.31 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow